ClinicalTrials.gg
Sign In

Metabolic Syndrome clinical trials

The registry lists 2,117 studies for Metabolic Syndrome across more than 10 countries. 347 are recruiting or about to start. 1,054 of them are mainly about Metabolic Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

ClinicalTrials.gov finds 6,059 studies for Metabolic Syndrome. How that becomes 2,115 here

This page counts the studies the registry files under Metabolic Syndrome, and those it files under no condition that list Metabolic Syndromethemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 6,059Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −28List Metabolic Syndrome as a condition, but the registry did not file them under itMost often written as “Abdominal Obesity Metabolic Syndrome” (7), “Cardiovascular-kidney-metabolic Syndrome” (7), and “Cardiovascular Kidney Metabolic Syndrome” (3). The registry filed them under other conditions only, most often Abdominal obesity metabolic syndrome (9) and Cardiovascular Diseases (8).
  3. −3,916Match it another way175 name it in the title, 9 in a keyword, and 3,732 by a synonym or other text the search reads.
  4. 2,115The count on this page19 of them list Metabolic Syndrome in their own words; the registry filed them under no condition.

Get an email when these change. Save the Metabolic Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
1,296
Status unknown
293
Recruiting
231
Not yet recruiting
91
Terminated
70
Active, not recruiting
66

Phase

Phase 2
168
Phase 4
139
Phase 3
106
Phase 1
52
Early Phase 1
21

Where

United States
579
Canada
120
Italy
95
China
89
Spain
89
France
74

Who runs them

Laval University (24) · Cairo University (21) · University of Copenhagen (20) · University of Toronto (17) · National Taiwan University Hospital (16) · University of Aarhus (14) · Massachusetts General Hospital (14) · Lund University (14)

What is being tested here

Drugs under test in Metabolic Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Semaglutide648
Empagliflozin447
Tirzepatide303
Berberine2310
Probiotic205
Telmisartan126
Liraglutide115
Anastrozole114
Dapagliflozin122
Thioctic Acid112

Drug classes tested here GLP-1 receptor agonists 9 open · SGLT2 inhibitors 5 open · Angiotensin receptor blockers (ARBs) 1 open · Integrase inhibitors 1 open · NSAIDs 1 open

Coming up

12phase 3 studies under way
117studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 231 Metabolic Syndrome studies recruiting now, 68 (29%) set no upper age limit and 135 (58%) stop at 75 or younger. 20 (9%) take children under 18. 22 (10%) are for women only and 8 (3%) for men only; 80 (35%) take healthy volunteers.

Recruiting studies that take each age, of 231
AgeWomenMen
1010 (4%)9 (4%)
18146 (63%)136 (59%)
30174 (75%)164 (71%)
40186 (81%)179 (77%)
50181 (78%)177 (77%)
65171 (74%)165 (71%)
75111 (48%)107 (46%)
8579 (34%)76 (33%)

Across all 2,117 studies, recruiting or not: 66% stop at 75 or younger and 46% at 65; 10% take children; 9% are for women only and 7% for men only; 41% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Metabolic Syndrome studies take

Of 32 phase 4 interventional studies under Metabolic Syndrome, half reached primary completion within 32 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 126 mo9–53 · 17 studies——
Phase 229 mo18–58 · 31 studies—30 mo26–62 · 28 studies
Phase 432 mo13–57 · 32 studies——
Interventional, no phase20 mo9–40 · 675 studies19 mo11–37 · 50 studies20 mo9–41 · 625 studies
Observational42 mo18–106 · 160 studies—43 mo18–106 · 149 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting4

Results posted1

Stopped1

Newly registered7

Show 2 more

Studies

Recruiting first, then most recently updated. Showing 50 of 2,117. Browse all 2,117 → or search them.